Simcere Pharmaceutical Group Limited (Simcere Pharma) has scheduled a board meeting for 20 August 2026. Directors will consider and approve the unaudited interim results for the six months ended 30 June 2026 and discuss a potential interim dividend.

The meeting agenda includes: 1. Review and approval of the Group’s 1H26 unaudited financial statements. 2. Deliberation on publication of the interim results. 3. Recommendation on the payment of an interim dividend, if any.

The Board is chaired by Mr. Ren Jinsheng, who also serves as an executive director. Other executive directors are Mr. Tang Renhong, Mr. Wan Yushan and Ms. Wang Xi, while Mr. Song Ruilin, Mr. Wang Jianguo, Mr. Wang Xinhua and Mr. Sung Ka Woon act as independent non-executive directors.

The announcement was released in Hong Kong on 10 August 2026.